載入...
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
Epithelial ovarian cancer (EOC) has an innate susceptibility to become chemoresistant. Up to 30% of patients do not respond to conventional chemotherapy [paclitaxel (Taxol®) in combination with carboplatin] and, of those who have an initial response, many patients relapse. Therefore, an understandin...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd.
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3593171/ https://ncbi.nlm.nih.gov/pubmed/22069160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.3035 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|